BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-637@pharmaconomics
DTSTAMP:20260707T045034Z
DTSTART;VALUE=DATE:20260324
DTEND;VALUE=DATE:20260325
SUMMARY:KPTI Phase 3 — selinexor
DESCRIPTION:Phase 3 trial results for selinexor in myelofibrosis are due Mar 24\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1503802/000119312526120770/d125009dex991.htm\n\nTrack it: https://www.pharmaconomics.com/e/637
URL:https://www.pharmaconomics.com/e/637
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:KPTI catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR